MIG Funds sell shares in B.R.A.I.N. AG
Certain MIG Funds that hold shares in B.R.A.I.N. Biotechnology Research and Information Network AG (“BRAIN”) (ISIN DE0005203947) have resolved today, to sell approx. half of their holding in BRAIN to institutional investors. The MIG Funds reserve the right to increase the number of shares. The funds currently hold in total approx. 2.5mn shares in BRAIN (representing together 15% of BRAIN’s total share capital). The MIG Funds have mandated an Investment Bank Syndicate that will sell shares to institutional investors in a private placement by way of an Accelerated Bookbuilding.
MIG is a German Venture Capitalist Investor that has – through various funds – been invested in BRAIN since 2006.
Munich, 8 February 2017
MIG Verwaltungs AG
on behalf of
MIG GmbH & Co. Fonds 3 KG; MIG GmbH & Co. Fonds 4 KG; MIG GmbH & Co. Fonds 5 KG,
Ismaninger Straße 102, 81675 München und MIG GmbH & Co. Fonds 13 geschlossene Investment-KG, Münchener Str. 52, 82049 Pullach
Further Information on MIG Funds are available at www.mig-fonds.de
08.02.2017 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
